The ESSENCE Study
Have you been diagnosed with (by liver biopsy), or are you at high risk of developing (have type 2 diabetes, are obese, and/or have high cholesterol), nonalcoholic steatohepatitis (NASH)? You may be able to participate in a study to evaluate an investigational drug for its ability to treat NASH. This study involves 21 visits and up to 9 phone calls over 5 years. Compensation is provided.